All Infectious Disease articles – Page 106
-
NewsIVI starts technology transfer to Biological E. Limited to manufacture oral cholera vaccine for India and global markets
The International Vaccine Institute (IVI) has announced that it has commenced a technology transfer of simplified Oral Cholera Vaccine (OCV-S) to Biological E. Limited (BE), a leading India-based vaccines and pharmaceutical company.
-
NewsInsights into release of fungal toxin promise progress in treating infections
The toxin Candidalysin of the yeast Candida albicans is incorporated into an unusual protein structure during an infection, and researchers have now succeeded in deciphering the function of this unusual arrangement.
-
NewsNewly identified yeast could prevent fungal infections by outcompeting rivals, study suggests
Researchers have identified a yeast that could be used to prevent invasive candidiasis, a major cause of death in hospitalized and immunocompromised patients.
-
NewsResearchers uncover how viruses choose whether to become nasty or not
Researchers have deciphered a novel complex decision-making process that helps viruses choose to turn nasty or stay friendly to their bacterial host.
-
NewsThe SNF Institute for Global Infectious Disease Research announces new advisory board
The Stavros Niarchos Foundation Institute for Global Infectious Disease Research at Rockefeller University (SNFiRU) has capped a successful first year with the establishment of a new advisory board.
-
NewsStudy shows potential for using AI tools to detect healthcare-associated infections
A new proof-of-concept study reports that artificial intelligence (AI) technologies can accurately identify cases of healthcare-associated infections (HAI) even in complex clinical scenarios.
-
NewsLives could be saved from tropical disease with new rapid test
A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster.
-
NewsTurns out that eating poo can be vital for birds’ survival
New research explains how eating faeces, known as coprophagy, shapes wild birds’ digestive tracts, enabling them to absorb lost or deficient nutrients and adjust to seasonal variations in food sources.
-
NewsNo persistent cough in 4 out of 5 with tuberculosis
A study of more than 600,000 individuals shows that 80% with TB have no persistent cough, previously believed to be the most common symptom of the infectious disease.
-
NewsTuberculosis bacteria present in 90% of those with symptoms - including those who test negative
Mycobacterium tuberculosis (Mtb) is present in exhaled breath of 90% of those presenting with suspected tuberculosis. This includes those who were negative on conventional sputum testing and not diagnosed with TB.
-
NewsCOVID-19 virus can stay in the body more than a year after infection
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended, according to new research that offers potential clues to why some people develop long COVID.
-
NewsWomen with high-risk HPV and metabolic syndrome have almost three times risk for mortality
Women with both metabolic syndrome and high-risk strains of human papillomavirus (HPV) are at a 2.6 times higher risk for mortality than women without either condition.
-
NewsRapid molecular testing in the emergency department leads to faster, targeted treatment for community-acquired pneumonia
Rapid molecular testing for patients hospitalised with suspected community-acquired pneumonia (CAP) significantly enhances the speed and accuracy of treatment.
-
NewsStudy reveals how virus hijacks insect sperm to control disease vectors and pests
A new study reveals how viral proteins from symbiotic bacteria cause sterility in insects.
-
NewsSTI cases on the rise across Europe
In 2022, the number of reported cases saw a significant increase compared to the previous year, with gonorrhoea cases rising by 48%, syphilis cases by 34%, and chlamydia cases by 16%.
-
NewsMalaria parasite generates genetic diversity using evolutionary ‘copy-paste’ tactic
Plasmodium falciparum, a malaria parasite, uses gene conversion to produce genetic diversity in two surface protein genes targeted by the human immune system.
-
NewsProtective human monoclonal antibody targets a conserved site of spike glycoprotein of SARS-CoV-2 Omicron variants
Scientists report that mAb-39 greatly improved the neutralizing activity of anti-RBD antibody, the same type of EUA therapeutic monoclonal antibodies, against the highly neutralization-resistant Omicron variants.
-
NewsThe future is personalised care for influenza and flu-like illness
A new research review will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors will be able to more accurately determine when the infectious part of the illness has passed.
-
NewsEvidence needed for preventative measures to stop surgical infections
A new research review will look at improving preventive measures to stop surgical infections. It will also ask why we are doing what we are doing, especially when some interventions lack quality evidence to back them.
-
NewsDrug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens.